Ellen Cavaleri

Investor Relations Contact at PTC THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Ellen Cavaleri is currently Head-Investor Relations at PTC Therapeutics, Inc. since 2024.
Formerly, worked as Senior VP-Investor Relations & Communications at Lyra Therapeutics, Inc. from 2022 to 2024, and served as Investor Relations Contact at Kadmon Holdings, Inc. Education includes an undergraduate degree from Vanderbilt University and an MBA from New York University.

Ellen Cavaleri active positions

Companies	Position	Start
PTC THERAPEUTICS, INC.	Investor Relations Contact	01/11/2024

All active positions of Ellen Cavaleri

Former positions of Ellen Cavaleri

Companies	Position	End
LYRA THERAPEUTICS, INC.	Investor Relations Contact	01/06/2024
KADMON HOLDINGS, INC.	Investor Relations Contact	-

See the detail of Ellen Cavaleri's experience

Training of Ellen Cavaleri

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ellen Cavaleri's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
PTC Therapeutics, Inc. PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases	Health Technology
Kadmon Holdings, Inc. Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs	Health Technology
Vanderbilt University Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lyra Therapeutics, Inc. Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases	Health Technology